Here are relevant reports on : fund-administration-market
-
US Identity and Access Management (IAM) Market by Technology [Access Management, Identity Governance & Administration (IGA), Privileged Access Management (PAM)], Type [Workforce, CIAM, 82B], Identity Type [Human, Non-human]-Forecast to 2030
The identity and access management (IAM) market in the US is expected to expand significantly, rising from USD 7.34 billion in 2025 to USD 11.09 billion by 2030 at a CAGR of 8.6%. The key players include Microsoft (US), Ping Identity (US), IBM (US), Okta (US), Oracle (US), SailPoint (US), Saviynt (US), CyberArk (US), Akamai Technologies (US), Entrust (US), RSA Security (US), Avatier (US), ManageEngine (US), SecureAuth (US), EmpowerID (US), Simeio (US), One Identity (US), FusionAuth (US), Auth0 (US), and Zuora (US).
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Vitamin D Therapy Market by Route of administration (Oral, Parenteral), Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases) - Global Forecast to 2024
The vitamin D therapy market is projected to reach USD 3.3 billion by 2024 from USD 1.9 billion in 2019, at a CAGR of 11.6% during the forecast period. Growth in this market is largely driven by the growing awareness about vitamin D deficiency and the presence of a large target patient population. On the other hand, the fortification of foods is likely to challenge the growth of this market. Some of the major players in this market include Abbott (US), Sanofi (France), GlaxoSmithKline plc (UK), Pfizer Inc. (US), Merck & Co., Inc. (US), Torrent Pharmaceuticals Ltd. (India), Novartis International AG (Switzerland), Alkem Laboratories (India), Sun Pharmaceutical Industries Ltd. (India), and Cadila Healthcare Ltd. (India).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Migraine Drugs Market by Product Type (Acute migraine treatment, Preventive migraine treatment), Route of administration (Oral, Injection, and Others), and End User (Hospital pharmacies, Retail pharmacies, Online pharmacies) - Global Forecast to 2023
The global Migrane Drugs market is expected to reach USD 3.96 billion by 2023 from USD 1.95 million in 2018, growing at a CAGR of 15.2%. Increasing awareness about novel therapies, launch of Calcitonin Gene-related Peptide (CGRP), increasing incidence of migraines and launch of new drugs are some of the major factors driving the growth of the global suture anchor market. These driving factors consequence to the rapid adoption of these new drugs, thus propelling the market growth.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Property Management Market by Software Type (Lease Management (Portfolio Management, Document Storage & Management, AI Lease Abstraction, Lease Accounting & Administration), Facility Management, Reporting & Analytics), End User - Global Forecast to 2030
The property management market size is projected to reach USD 42.78 billion by 2030, at a CAGR of 8.3% during the forecast period. Some major players in the property management market include Oracle (US), IBM (US), Appfolio (US), SAP (Germany), Hitachi Vantara (US), Yardi (US), RealPage (US), SS&C (US), Trimble (US), Eptura (US), CoStar Group (US), Hemlane (US), Entrata (US), Rent Manager (US), Rentec Direct (US), Re-leased (UK), Doorloop (US), Stessa (US), JLL (US), MCS Rental Software (UK), Accruent (US), Planon (Netherlands), Guesty (Israel), Hive (Germany), Avail (Sweden), Property Matrix (US), HappyCo (US), Resman (US), Innago (US), Finquery (US), Rentredi (US), Turbotenant (US), Breezeway (US), Livly (US), SimplifyEm (US), Condo Control (US) and PayHOA (US)
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Middle East & Africa Injectable Drug Delivery Market by Product (Device, Needle-free injectors, Formulation, Solutions), Formulation Packaging (Vials, Cartridges), Therapeutic Application (Diabetes, Psoriasis), Site of Administration – Forecast to 2031
The Middle East & Africa injectable drug delivery market, valued at US$15.46 billion in 2025, stood at US$16.46 billion in 2026 and is projected to advance at a resilient CAGR of 6.5% from 2026 to 2031, culminating in a forecasted valuation of US$22.54 billion by the end of the period. The demand for fill-and-finish services is increasing, contributing to the growth of the injectable drug delivery market in the Middle East & Africa.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
US General Anesthesia Drugs Market by Route of Administration (Intravenous and Inhalational), End User (Hospitals, Ambulatory Surgery Centers) - Global Forecast to 2025
The global US general anesthesia drugs market in terms of revenue was estimated to be worth $2.0 billion in 2020 and is poised to reach $2.4 billion by 2025, growing at a CAGR of 3.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Contrast Media Market By Type (lodinated Contrast Media), Form (Liquid, Powder), Modality (X-ray, MRI, Ultrasound), Route of Administration (Oral, Rectal), Indication (Cancer, Neurological, GI, Musculoskeletal Disorders) & Region - Global Forecast to 2031
The Contrast Media market, valued at USD 7.65 billion in 2025, stood at USD 8.20 billion in 2026 and is projected to advance at a resilient CAGR of 7.9% from 2026 to 2031, culminating in a forecasted valuation of USD 12.08 billion by the end of the period. Factors driving this growth include the increase in people with chronic conditions, like cardiovascular disease, cancer and neurological disorders, and, also, increase in the number of people getting diagnostic imaging tests on a global basis.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Vaccines Market by Type (Porcine, Poultry, Bovine, Ruminant, Canine, Feline, Aquaculture), Technology (Live Attenuated, Inactivated, Toxoid, Recombinant), Route of Administration (Subcutaneous, Oral), End User - Global Forecast to 2031
The global veterinary vaccines market is projected to reach USD 18.46 billion by 2031, growing at a CAGR of 7.2% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Drug Delivery Market By Administration Route (Oral, Injectable, Topical, Ocular, Nasal, Transmucosal & Implantable, Pulmonary, Transdermal Patch), Application (Cancer, Diabetes, Cardiovascular), Facility of Use - Global Forecast to 2031
The global pharmaceutical drug delivery market is projected to reach USD 2,922.82 billion by 2031, growing at a CAGR of 6.3% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Europe Infusion Pump Market by Product [Accessories (Dedicated, Non-dedicated), Device (Insulin, Syringe, Volumetric, Enteral, PCA Pump)], Application (Chemotherapy, Diabetes, Analgesia), Mode of Administration (Subcutaneous, Epidural) - Forecast to 2031
The Europe infusion pump market, valued at USD 4.78 billion in 2025, stood at USD 5.10 billion in 2026 and is projected to advance at a resilient CAGR of 6.8% from 2026 to 2031, culminating in a forecasted valuation of USD 7.09 billion by the end of the period.
- Published: October 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
